CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,819 | -47.7% | 123,308 | -0.2% | 0.00% | – |
| Q2 2023 | $443,362 | +4.4% | 123,499 | -2.0% | 0.00% | – |
| Q1 2023 | $424,543 | +146.0% | 125,977 | +13.1% | 0.00% | – |
| Q4 2022 | $172,581 | +23.3% | 111,343 | +7.5% | 0.00% | – |
| Q3 2022 | $140,000 | -79.3% | 103,552 | -66.5% | 0.00% | – |
| Q2 2022 | $677,000 | +11.0% | 309,112 | +61.5% | 0.00% | – |
| Q1 2022 | $610,000 | -18.1% | 191,349 | +7.4% | 0.00% | – |
| Q4 2021 | $745,000 | -62.8% | 178,147 | -27.7% | 0.00% | – |
| Q3 2021 | $2,000,000 | +12.2% | 246,362 | +4.3% | 0.00% | – |
| Q2 2021 | $1,783,000 | +2.2% | 236,123 | +17.5% | 0.00% | – |
| Q1 2021 | $1,744,000 | +6.0% | 200,957 | -2.7% | 0.00% | – |
| Q4 2020 | $1,646,000 | +15.6% | 206,571 | +15.6% | 0.00% | – |
| Q3 2020 | $1,424,000 | -16.0% | 178,623 | +4.4% | 0.00% | – |
| Q2 2020 | $1,695,000 | -16.7% | 171,158 | -35.0% | 0.00% | -100.0% |
| Q1 2020 | $2,034,000 | +38.7% | 263,136 | -30.9% | 0.00% | – |
| Q4 2019 | $1,466,000 | +253.3% | 380,882 | +360.9% | 0.00% | – |
| Q3 2019 | $415,000 | +64.7% | 82,635 | +117.1% | 0.00% | – |
| Q2 2019 | $252,000 | -19.7% | 38,055 | -8.3% | 0.00% | – |
| Q1 2019 | $314,000 | -46.5% | 41,513 | -42.9% | 0.00% | – |
| Q4 2018 | $587,000 | -41.8% | 72,689 | -7.0% | 0.00% | – |
| Q3 2018 | $1,008,000 | +3.0% | 78,200 | -8.9% | 0.00% | – |
| Q2 2018 | $979,000 | +500.6% | 85,872 | +270.2% | 0.00% | – |
| Q1 2018 | $163,000 | +213.5% | 23,193 | +187.9% | 0.00% | – |
| Q4 2017 | $52,000 | +20.9% | 8,056 | +17.4% | 0.00% | – |
| Q3 2017 | $43,000 | +290.9% | 6,862 | +173.7% | 0.00% | – |
| Q2 2017 | $11,000 | -76.1% | 2,507 | -76.1% | 0.00% | – |
| Q1 2017 | $46,000 | +283.3% | 10,482 | +354.6% | 0.00% | – |
| Q4 2016 | $12,000 | -14.3% | 2,306 | +8.3% | 0.00% | – |
| Q3 2016 | $14,000 | +40.0% | 2,130 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -23.1% | 2,130 | -36.5% | 0.00% | – |
| Q1 2016 | $13,000 | 0.0% | 3,354 | +39.9% | 0.00% | – |
| Q4 2015 | $13,000 | -18.8% | 2,398 | -2.8% | 0.00% | – |
| Q3 2015 | $16,000 | -97.8% | 2,467 | -97.9% | 0.00% | – |
| Q2 2015 | $715,000 | +13.1% | 116,570 | +143.2% | 0.00% | – |
| Q1 2015 | $632,000 | – | 47,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |